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Chronic respiratory alkalosis induces renal hyperphosphatemia and
hypocalcemia in humans. The effects of chronic respiratory alkalosis on
divalent ion homeostasis have not been reported in any species. We
studied four normal male subjects during a four-day control period
(residence at 500 m), during six days of chronic respiratory alkalosis
induced by hypobaric hypoxia (residence at 3450 m), followed by a
six-day eucapnic recovery period (500 m) under metabolic balance
conditions. Chronic respiratory alkalosis (PaCO2, —8.4 mm Hg,
[H] —3.2 nmol/liter) resulted in a sustained decrement in plasma
ionized calcium concentration ([IoCa], —0.10 mmol/liter, P <
0.05) and a sustained increment in plasma phosphate concentration(A[PO4], +0.14 mmollliter, P < 0.005) associated with increased
fractional excretion of Ca (+0.5%, P <0.005), decreased phosphate
clearance (—6.1 mI/mm, P < 0.025) and decreased excretion of nephro-
genous cAMP (—1.5 nmol/l00 ml GFR, P <0.0025). Urinary phosphate
excretion decreased by 15.4 mmol/24 hr on day I of chronic respiratory
alkalosis (P < 0.0025), but returned to control values by day 6 despite
hyperphosphatemia. Serum intact PTH1 did not change. Sustained
hypomagnesuria (—0.8 mmol/24 hr, P < 0.05) occurred during chronic
respiratory alkalosis and was accounted for, at least in part, by
decreased fractional excretion of Mg (—0.7%, P < 0.05) in the
absence of change in plasma magnesium concentration. Serum
I,25(OH)2D levels were unchanged by chronic respiratory alkalosis. In
conclusion, the decrease in nephrogenous cAMP generation despite
unchanged serum intact PTH concentration suggests that chronic
respiratory alkalosis results in impaired renal responsiveness to PTH as
manifested by alterations in PTH-dependent renal calcium and phos-
phate transport. Hypomagnesuria in chronic respiratory alkalosis may
be due, at least in part, to hypocalcemia-induced enhancement of renal
magnesium reabsorption. The failure of [PTH] to increase during
hypocalcemia may reflect defective PTH secretion.
Chronic respiratory alkalosis is the commonly encountered
acid-base disorder initiated and sustained by a primary reduc-
tion in arterial carbon dioxide tension (hypocapnia), which, in
turn, results in secondary hypobicarbonatemia due to hypocap-
nia-induced suppression of renal acid excretion [1, 2]. Frequent
clinical settings for chronic respiratory alkalosis include tissue
hypoxia, malignancy, neurologic disorders, pregnancy, and
hepatic failure. Since diverse alterations in divalent ion metab-
olism also occur in these settings [3—61, a precise characteriza-
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tion of the potential independent role of chronic hypocapnia in
producing disorders of mineral metabolism is of substantial
clinical importance.
Calcium and phosphorus homeostasis has been characterized
incompletely in chronic respiratory acid-base disorders. In
chronic hypercapnia produced in dogs by exposure to a 10%
CO2 atmosphere, sustained hypercalciuria occurs despite no
changes in filtered Ca load, total plasma calcium concentra-
tion, blood ionized Ca concentration, serum PTH, and
1,25(OH)2D concentration [7]. These results suggest that im-
paired renal tubular calcium reabsorption is responsible, at least
in part, for the observed increase in fractional Ca excretion.
A preliminary report in rats has also documented hypercalciuria
during sustained hypercapnia [81.
No data are currently available in any species which charac-
terize the plasma or urinary calcium response to chronic
hypocapnia. Acute hypocapnia induced by voluntary hyperven-
tilation in human volunteers results in no significant change in
plasma total calcium concentration [9, 10]. However, small but
statistically significant reductions in plasma ionized [Cat 1
have been reported in both rats and humans [11, 12], which
average about —0.4 mmoLlliter per pH unit. The magnitude of
this acute decrease in plasma ionized [Ca] is similar to that
observed in vitro as the net result of counter-balancing pH-
induced changes in albumin-Ca binding and HCO3-Ca
complex dissolution [11—16]. There are no reports evaluating
urinary calcium excretion during acute hypocapnia in humans.
A single report in dogs suggested no change in urinary calcium
excretion [171. The reported effects of chronic chloride deficien-
cy-induced metabolic alkalosis on calcium and PTH homeosta-
sis might be of value in predicting the results of studies of
chronic respiratory alkalosis [18]. These studies demonstrated
that an alkalosis of metabolic origin resulted in chronic hypo-
calcemia with a secondary increase in plasma PTH concentra-
tion accompanied by hypocalciuria and increased tubular reab-
sorption of Ca , possibly PTH-driven. The etiology of
hypocalcemia, however, was not determined.
Reported measurements of the plasma and urinary phospho-
rus responses to chronic hypocapnia are limited to studies in
dogs which showed reversible hyperphosphatemia, but did not
provide values for daily phosphorus excretion nor estimates of
GFR to permit assessment of the role of the kidney in altered
phosphorus horneostasis [19—21]. No data have been reported
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Table 1. Effect of chronic hypocapnia on steady-state mineral metabolism
Period
PaCO2
mm Hg
Ca P04 Mg Intact PTH 1,25(OH)2D
mmol/liter pg/mi
Control 39.1 0.6 1.17 0.02 1.03 0.04 0.82 0.03 23.0 3.2 26.3 3.8
Hypocapnia 30.7 Q,4 1.07 0.02a 1.17 0.05" 0,85 0.02 26.2 4.8 24.8 4.2
Recovery 38.3 O.9 1.14 o.ola 1.08 0,05b 0.83 0.03 28.2 4.2 24.2 4.1
Plus-minus values are means SE. Abbreviations are: PaCO2, arterial carbon dioxide tension; Ca, ionized ëalcium; P04, phosphate; Mg,
magnesium; PTH, intact parathyroid hormone; 1 ,25(OH)2D, I ,25-dihydroxycholecalciferol. For definition of study periods see Methods section.
To convert mm Hg into kilopascals, multiply by 0.1333. Steady state values are means of values from the last three days of each period.
a p < 0.001 for the comparison with the previous steady-state period (control or hypocapnia)
b p < 0.005 for the comparison with the previous steady-state period (control or hypocapnia)
describing the plasma and urinary magnesium response to
chronic hypocapnia in any species. Acute hypocapnia resulted
in no change in plasma magnesium concentration in dogs [17].
No data have been reported describing the responses of PTH or
vitamin D metabolites to chronic hypocapnia in any species.
Accordingly, the present studies were undertaken to examine
the impact of chronic hypocapnia in humans on divalent cation,
phosphorus, parathyroid hormone and I ,25(OH)2D metabo-
lism.
Methods
The protocol was designed to determine the effects of chronic
hypocapnia on divalent cation, phosphate, PTH, and
1 ,25(OH)2D metabolism in normal subjects. Four normal male
volunteers [mean age (± SD) 26.3 3.7 years; weight, 71.9
6.4 kg] were studied during a four-day control period [residence
at 500 m, partial pressure of oxygen 150 mm Hg, (20 kPa)],
during six days of chronic hypocapnia induced by hypobaric
hypoxia [residence at the High Alpine Research Station, Jung-
fraujoch, Swiss Alps, altitude 3450 m, partial pressure of
oxygen 104 mm Hg (13.9 kPa)], followed by a six-day eucapnic
recovery period (residence at 500 m) under metabolic balance
conditions. All subjects were medical students who volunteered
for the study, were paid for participation, and gave informed
consent. None were smokers or were taking any drugs before or
during the study. Transfer to and from the High Alpine Re-
search Station was performed by train in less than four hours.
The subjects ingested a constant metabolic diet for at least six
days before the study (prestudy phase) and during all three
study periods (control, hypocapnia, and recovery). The diet
provided the following for every kilogram of body weight per
day: sodium 1.75 mmol, potassium 1.53 mmol, calcium 0.395
mmol (15.8 mg), phosphate 0.51 mmol (15.8 mg), nitrogen 15.7
mmol (0.22 g), water 40.7 ml, and 35 kCal.
Daily fasting, arterialized venous blood samples were ob-
tained in a heparin-coated syringe from a heated hand or
forearm vein [22]. Blood samples were accepted only if the
partial pressure of oxygen was greater than 70 mm Hg (9.3 kPa).
Weight and oral temperature were measured at the time of
blood sampling; 24-hour urine samples were collected in plastic
bottles containing mineral oil and thymol-chloroform preserva-
tive. Exercise was limited to minimal ambulation throughout
the study. During each study period, a subject was considered
to be in a steady state when plasma values obtained on three
consecutive days varied by no more than 1.5 mmol/per liter for
bicarbonate and by no more than 3 mm Hg (0.4 kPa) for PaCO2.
Analytical procedures
All determinations were performed in duplicate. Acid-base
and electrolyte values in blood and urine were determined as
described previously [2]. Ionized calcium was measured with an
ion-selective electrode (Ciba-Corning, Model 634). Phosphate
was determined by the method of Fiske and Subbarow [23].
Serum intact parathyroid hormone [24] and l,25(OH)2D con-
centration [25] were measured with specific radioimmunoassay/
radioreceptor assay kits (Nichols Institute, San Juan Capis-
trano, California, USA). cAMP in plasma and urine was
determined by radioimmunoassay kit (Amersham, Arlington
Heights, Illinois, USA). Nephrogenous cAMP was calculated
according to the method of Broadus et al [26]. Results are
reported as means standard error of the mean (SE) unless
stated otherwise. Statistical significance was determined by
two-tailed t-test for paired data.
The study protocol was approved by the ethics committee of
the University of Berne School of Medicine.
The steady state plasma and urinary acid-base composition,
creatinine clearance, and plasma albumin levels of these sub-
jects have been the subject of a previous report [2].
Results
Chronic exposure to hypobaric hypoxia resulted in significant
hypocapnia with a decrease in PaCO2 from 39.1 0.6 to 30.7
0.4 mm Hg (P < 0.001, Table 1). In response to hypocapnia,
blood hydrogen ion concentration decreased from 36.9 0.3 to
33.7 0.3 nmol/liter (P < 0.001), while plasma bicarbonate
concentration decreased from 25.2 0.4 to 21.7 0.5 mmol/
liter (P < 0.001). Chronic hypocapnia resulted in a small
increase in plasma albumin concentration from 44.0 1.1 to
45.8 1.1 gfliter (P < 0.05), but did not result in significant
changes in creatinine clearance (Table 2), body weight and
hematocrit (data not shown),
The effects of chronic respiratory alkalosis on steady-state
blood ionized calcium, plasma phosphate, magnesium, serum
intact parathyroid hormone and 1 ,25(OH)2D concentrations are
depicted in Table I. Table 2 shows the effect of chronic
hypocapnia on urinary net acid, electrolyte, calcium, phos-
phate, magnesium and nephrogenous cAMP (ncAMP) excretion
as well as its effects on the fractional excretions (FE) of calcium
and magnesium. The natriuretic response to hypocapnia was
most prominent on day 1 and was absent by day 6 (mean day 6
urinary sodium excretion 120.1 mmoIJ24 hr).
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Table 2. Effect of chronic hypocapnia on urinary net acid, electrolyte, mineral and ncAMP excretion
ncAMP
Net acid Na K C1 Ca P04 Mg FE FEMg
%
P04
clearance
mi/mm
nmol/
100 ml
GFR
Creatinine
clearance
mi/secmmol/24 hr
Control 44.4 114.5 91.4 123.3 5.87 28.9 6.1 1.88 3.73 19.5 1.77 2.33
Hypocapnia
Day 1 5.0k 158.0 72.la 128.6 5.90 10.9 4.8 2.60' 310C 100b 055
Days 4—6
A (Day 6)
419b 1305b
+l53e
85.9 124.1
+27
5.4
—2.42
23.7 5.0 2.48"
—
324d
—
138b
—
0.55a
7.iof
2.15
Recovery
Day 1 47.5" 139.9 960b 133.6 5.21 25.8" 6.7 165b 395b 14.2 1.25"
Days 4—6 Sl.S 105.9" 94.8 119.7 5.03 35.0' 6.4 187b 3.88" 22.3" 1.72a 2.28
(Day 6) +69e 139" 55e +6 —2.0 +3l +9.8' — — — ÷6.4f
Plus-minus values are meansSE. denotes the cumulative change in excretion, calculated as the accumulated sum of the daily differences
from the mean value of the previous steady-state period.
P < 0.001
bp<0005
< 0.025 vs. the previous steady-state period
d P < 0.05
. }
significantly different from zero
Chronic respiratory alkalosis resulted in a significant and
sustained decrease in renal phosphate clearance (Table 2, Fig.
1) as well as in significant steady-state hyperphosphatemia
(Table 1, Fig. 1). During eucapnic recovery, both phosphate
clearance and plasma phosphate concentration returned to
control values (Tables 1 and 2, Fig. 1). Urinary phosphate
excretion decreased by 15.4 mmol/24 hr on day 1 of chronic
respiratory alkalosis (P < 0.0025), but returned to control
values by day 6 despite hyperphosphatemia. Chronic hypocap-
nia induced a significant decrease in blood ionized calcium
concentration that occurred in association with a significant and
persistent increase in the fractional excretion of calcium (FECa,
Tables 1 and 2, Fig. 1). FEa and blood ionized calcium
concentration returned to control values during eucapnic recov-
ery. Importantly, these changes occurred without significant
alterations in the cumulative change in urinary calcium excre-
tion (sum of the daily changes in urinary calcium excretion from
the previous steady-state mean value, Table 2).
Chronic respiratory alkalosis also resulted in a large and
reversible decrease in ncAMP excretion of —1.5 0.14 nmol/
100 ml GFR (P < 0.0025, Table 2, Fig. 2). Despite steady-state
ionized hypocalcemia and hyperphosphatemia, there were no
significant changes in the serum concentrations of either intact
PTH or 1,25(OH)2D (Table 1, Fig. 2). Sustained hypomag-
nesuria was observed during chronic respiratory alkalosis (—0.8
mmoll24 hr, P < 0.05) and was accounted for in part, by
decreased FEMS (—0.7%, P < 0.05) despite no change in plasma
magnesium concentration (Table 2, Fig. 3).
Discussion
The present study is the first to examine the effects of chronic
respiratory alkalosis on divalent ion, PTH and l,25(OH)2D
metabolism in humans. The key findings summarized in Figure
4 are: (1) chronic respiratory alkalosis results in sustained
hyperphosphatemia and hypocalcemia; (2) renal phosphate
clearance decreases while fractional excretion of calcium in-
creases despite hyperphosphatemia and hypocalcemia, respec-
tively; (3) nephrogenous cAMP excretion decreases; and (4)
there are no significant changes in serum intact PTH and
1 ,25(OH)2D concentrations.
The findings of persistent hypocalcemia during sustained
hypocapnia in humans was unexpected. Whereas it is well
known that acute hypocapnia in both humans and rats can
result in hypocalcemia [approximately —0.4 mmol/L (Ca) per
pH unit], the magnitude of alkalemia in the present studies can
account for only a small fraction (13%) of the observed hypo-
calcemia [11—16]. Moreover, even if acute acid-base-induced
alterations in albumin-Ca binding and/or HCO3-Ca corn-
plexation did operate to produce sudden hypocalcemia of small
magnitude, there is no precedent for such changes to be
sustained inasmuch as numerous potent counter-regulatory
mechanisms defend against prolonged changes in ionized cal-
cium concentration [such as PTH and 1,25(OH)2D]. PTH
hypersecretion in response to hypocalcemia has been detected
with a minimum sensitivity of 0.025 mmol/liter ionized Ca +
[27, 281. Although acute hyperphosphatemia can reduce plasma
ionized calcium concentration in humans and experimental
animals [29] by virtue of CaHPO4 complexation, this explana-
(ion is insufficient to account for our results in chronic hypo-
capnia, since the magnitude of this effect accounts for less than
3% of the observed hypocalcemia.
The present study demonstrates that chronic hypocapnia
does not result in significant changes in urinary calcium excre-
tion in normal subjects. However, since creatinine clearance
was unchanged by hypocapnia, sustained hypocalcemia during
hypocapnia indicates a sustained reduction in the filtered load
Urinary
,Po4
excretion
mmol/24 hr
Fig. 1. Effects of chronic hypocapnia on
plasma ionized fCa ] and plasma phosphate
(P04) concentration, fractional excretion of
calcium (FEa), urinary phosphate excretion
and phosphate clearance. Urinary PO4
excretion denotes the daily changes in
phosphate excretion in comparison to the
previous steady-state period (that is, control
and hypocapnia, respectively). IPO4
excretion (• •) denotes the sum of the
daily changes in urinary phosphate excretion
from the previous steady-state period mean
excretion value.
of calcium. As depicted in Figures 1 and 4, this constellation of
findings indicates that sustained hypocapnia results in both an
early (24 hr) and sustained increase in the fractional excretion of
calcium. This observation indicates that, however generated, a
sustained impairment in renal calcium reabsorption is respon-
sible, at least in part, for the maintenance of chronic hypocal-
cemia. Moreover, the finding that steady-state urinary calcium
excretion during hypocapnia was unchanged from control val-
ues excludes the possibility that decreased gastrointestinal
calcium absorption was responsible, even in part, for the steady
state of hypocalcemia observed in the present studies. That is,
a putative hypocapnia-induced decrease in steady-state (days 4
to 6) net gut calcium absorption would obligate a decrease in
steady-state urinary calcium excretion (in the presence of a
constant dietary calcium intake) which was not observed. Only
a hypocapnia-induced steady-state increase in bone calcium
efflux could account for an unchanged urinary calcium excre-
tion rate in the presence of decreased gut absorption. Since
acidosis (not alkalosis) is reported to increase bone calcium
efflux, a role for the gastrointestinal tract in hypocapnia-
induced hypocalcemia is excluded [30].
Our data demonstrate that chronic hypocapnia induces "rel-
ative" hypoparathyroidism, that is, no change in PTH concen-
tration despite significant hypocalcemia. Consequently, the
coexistence of impaired renal calcium reabsorption and hypo-
calcemia observed during chronic hypocapnia might be inter-
preted to result from hypoparathyroidism. However, both
animal and human studies [3 1—35] have demonstrated that,
under ordinary dietary conditions, renal calcium reabsorption is
tonically stimulated by normal concentrations of PTH, Thus,
the possibility requires consideration that an additional defect
in the renal action of PTH exists, explaining the increased
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Time, days
fractional excretion of calcium despite hypocalcemia and sup-
pressed phosphate clearance in the setting of hyperphos-
phatemia. Our findings of a large decrease in nephrogenous
cyclic AMP excretion in response to chronic hypocapnia with-
out change in serum intact PTH concentration provides strong
evidence for this hypothesis. Thus, chronic hypocapnia induced
a state of renal tubular resistance to the cellular action of PTH,
that is functional pseudohypoparathyroidism, type I [361.
Therefore, the present results demonstrate that chronic hypo-
Fig. 2. Effects of chronic hypocapnia on the
urinary excretion of nephrogenous cyclic
AMP (ncAMP) and serum intact parathyroid
hormone (PTH) and J,25(OH)2D levels.
Fig. 3. Effects of chronic hypocapnia on
plasma and urinary magnesium (Mg)
homeostasis. Urinary Mg excretion denotes
the daily changes in urinary magnesium
excretion as compared with the previous
steady-state period mean excretion value
(control and hypocapnia, respectively). E
Mg excretion (• •) denotes the
cumulative changes in urinary Mg excretion
from the previous steady-state period. FEMg
denotes fractional urinary excretion of
magnesium.
capnia interferes at two sites of PTH metabolism: The acid-base
disorder inhibits both PTH secretion' and renal responsiveness
Whereas it is recognized that the steady-state plasma concentration
of a hormone is co-determined by its metabolic clearance rate as well as
its secretion rate, both acute and steady state alterations in the plasma
concentration of PTH in non-uremic subjects and animals have been
attributed largely to altered secretion in a wide variety of physiologic
and pathophysiologic states [37, 38].
Urinary
z[Mg]
excretion
mmol/24 hr
FEM9
%
2
0
—2
4
3
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to PTH. The mechanism of hypocapnia-induced renal resis-
tance to PTH action remains to be investigated, but might
involve a decreased number of renal cellular PTH receptors, an
alteration in receptor affinity for PTH, or post-receptor abnor-
malities (cyclic AMP production and/or degradation rate).
In addition to the hypocapnia-induced changes in PTH me-
tabolism, the chronic hypocalcemia observed in these studies
might also result from some consequence of deranged plasma
acid-base composition, per se, for example decreased blood
hydrogen ion or plasma bicarbonate concentration, or de-
creased PaCO2. Precedent for alkalemia-induced chronic hy-
pocalcemia is the finding of sustained hypocalcemia in a model
of chronic metabolic alkalosis in rats [18]. In contrast to the
present observations in humans, however, alkalemia was asso-
ciated with a physiological increase in PTH concentration in
response to hypocalcemia in the rat model. Based on both
clearance studies in dogs [39—411 and proximal tubule micro-
perfusion studies in rats 1421, we cannot, however, exclude the
possibility that hypocapnia-induced hypobicarbonatemia
(and/or decreased filtered load of HCO) might impair renal
calcium reabsorption, and thereby result in hypocalcemia.
Possible effects of alterations in PaCO2 on renal and systemic
calcium homeostasis independent of pH and HC03 have not
been reported to date.
The present study also demonstrates transient hypophospha-
tuna and a concomitant tendency to hypophosphaternia in the
first 48 hours of sustained hypocapnia, a finding consistent with
previous studies of acute hypocapnia in humans [9, 43]. The
hypophosphatemia of acute hypocapnia has been attributed to
sequestration of extracellular phosphorus in muscle cells in the
form of phosphate, adenine nucleotides and glucose-6-phos-
phate, owing to cell alkalinity-induced stimulation of glycolysis
1441. By the final day of hypocapnia in our subjects (Fig. 1),
however, sustained hyperphosphatemia was observed in the
C R
Plasma
P04
mmol/iiter
Plasma
[Ca+*}
mmoi/liter
P04
clearance
mi/mm
Fig. 4. Summary of the effects of chronic
hypocapnia on steady-state divalen: ion
metabolism. C, H, R denote control,
hypocapnia and recovery periods,
respectively.
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presence of a return of urinary phosphate excretion to control
values and suppressed P04 clearance, a constellation of findings
indicating sustained renal hyperabsorption of phosphate. Dur-
ing recovery, hyperphosphatemia diminished and was accom-
panied by phosphaturia. Our results are consistent with studies
in dogs which documented reversible hyperphosphatemia asso-
ciated with a cumulative decrease in renal phosphate excretion
in response to chronic hypocapnia [19—21]. However, these
reports precluded assessment of the role of the kidney in the
maintenance of hyperphosphatemia because data for daily
phosphate excretion and estimates of glomerular filtration rate
were not provided.
Finally, the present study demonstrates sustained hypomag-
nesuria in response to chronic hypocapnia without change in
the filtered load of magnesium. Enhancement of tubular mag-
nesium reabsorption in response to acute metabolic alkalosis is
well known [39, 45]. Whether alkalemia of respiratory origin
can stimulate renal magnesium transport remains to be deter-
mined. However, hypocalcemia, per se, has been demonstrated
to cause enhanced tubular magnesium reabsorption in thyropara-
thyroidectomized dogs [46]. The present results do not permit
the distinction between a putative alkalemic versus hypocalce-
mic effect of chronic hypocapnia to augment tubular magnesium
reabsorption in humans.
In conclusion, sustained respiratory alkalosis in humans
induces hyperphosphatemia and hypocalcemia, at least in part
of renal origin. The decreased excretion rate of nephrogenous
cAMP which accompanied the alterations in renal calcium and
phosphate transport despite unchanged serum PTH concentra-
tions, suggests that chronic hypocapnia induces renal resistance
to PTH, that is, functional pseudohypoparathyroidism, Type I.
In addition, the observed failure of PTH concentration to
increase in response to sustained hypocalcemia reflects a hy-
pocapnia-induced defect in PTH secretion, that is, relative
hypoparathyroidism.
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